Samantha Young

Visit kff.org to read Samantha's bio.

syoung@kff.org
@youngsamantha

California Handed Its Medicaid Drug Program to One Company. Then Came a Corporate Takeover.

The company awarded the state’s Medi-Cal Rx contract was taken over by another company, Centene. That left the state with a contractor it didn’t pick — one that has been accused of overbilling nine other state Medicaid programs and is now under investigation by California.

Newsom’s Big Promises on Drug Prices Are Slow to Materialize

Gov. Gavin Newsom has launched several initiatives to cut rising drug prices, but the savings haven’t been as monumental as he promised. And his plan to have California make its own generic drugs hasn’t gotten off the ground.

Changes to Medi-Cal’s Troubled Drug Program Reduce Backlog, but Problems Persist

After a troubled start to the new Medi-Cal prescription drug program, the state’s contractor has hired staffers to reduce wait times for medication approvals and patients seeking help. But some doctors and clinics report that patients continue to face delays.

Clinics Say State’s New Medicaid Drug Program Will Force Them to Cut Services

On Jan. 1, California started buying prescription drugs for its nearly 14 million Medicaid enrollees, a responsibility that had primarily been held by managed-care insurance plans. State officials estimate California will save hundreds of millions of dollars by flexing its purchasing power, but some health clinics expect to lose money.

California Ballot Will Be Heavy on Health Care

In the Nov. 8 general election, California voters will consider overturning the state’s flavored tobacco ban and hiking medical malpractice awards. Other proposals to decriminalize psychedelic mushrooms, target dialysis clinics and boost public health funding could also be on the ballot, along with a plan to limit business and school closures during public health emergencies.

After ‘Truly Appalling’ Death Toll in Nursing Homes, California Rethinks Their Funding

California wants to hold nursing homes accountable for the quality of care they provide by tying Medicaid funding more directly to performance. But the nursing home industry, an influential player in the Capitol, is gearing up for a fight.